Hsbc Holdings PLC Neurocrine Biosciences Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 223,258 shares of NBIX stock, worth $28.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

223,258

Previous 113,073 97.45%

Holding current value

$28.1 Million

Previous $15.6 Million 65.12%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $12.6 Million - $16.9 Million	110,185 Added 97.45%	223,258 $25.7 Million
Q2 2024 Aug 12, 2024	SELL	$130.86 - $143.19 $3.51 Million - $3.84 Million	-26,793 Reduced 19.16%	113,073 $15.6 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $4.68 Million - $5.16 Million	35,910 Added 34.54%	139,866 $19.3 Million
Q4 2023 Feb 12, 2024	BUY	$106.07 - $132.76 $2.76 Million - $3.45 Million	25,975 Added 33.31%	103,956 $13.7 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $95,148 - $118,505	1,012 Added 1.31%	77,981 $8.77 Million
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $3.4 Million - $3.98 Million	-37,946 Reduced 33.02%	76,969 $7.26 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $3.45 Million - $4.5 Million	36,616 Added 46.76%	114,915 $11.6 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $1.1 Million - $1.31 Million	10,291 Added 15.13%	78,299 $9.35 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $859,008 - $1.01 Million	9,334 Added 15.91%	68,008 $7.22 Million
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $39,259 - $51,836	518 Added 0.89%	58,674 $5.72 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $346,383 - $453,286	4,781 Added 8.96%	58,156 $5.45 Million
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $714,858 - $953,324	8,975 Added 20.21%	53,375 $4.55 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $1.19 Million - $1.37 Million	13,817 Added 45.18%	44,400 $4.26 Million
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $1.82 Million - $2.08 Million	20,357 Added 199.07%	30,583 $2.98 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $542,058 - $739,086	-6,190 Reduced 37.71%	10,226 $994,000
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $119,848 - $149,387	1,379 Added 9.17%	16,416 $1.57 Million
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $340,406 - $478,431	-3,540 Reduced 19.06%	15,037 $1.45 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $1.02 Million - $1.56 Million	11,975 Added 181.38%	18,577 $2.27 Million
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $607,639 - $920,318	-8,090 Reduced 55.06%	6,602 $572,000
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $350,585 - $478,904	-4,039 Reduced 21.56%	14,692 $1.59 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $440,054 - $532,875	5,250 Added 38.94%	18,731 $1.69 Million
Q2 2019 Aug 13, 2019	BUY	$72.24 - $91.27 $251,828 - $318,167	3,486 Added 34.88%	13,481 $1.14 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $9.5 Million - $12.5 Million	-137,106 Reduced 93.21%	9,995 $880,000
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $8.99 Million - $16.4 Million	131,592 Added 848.49%	147,101 $10.5 Million
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $1.53 Million - $1.95 Million	15,509 New	15,509 $1.9 Million
Q1 2018 May 11, 2018	SELL	$75.88 - $92.43 $437,448 - $532,858	-5,765 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $337,425 - $447,306	5,765	5,765 $447,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Neurocrine Biosciences Inc Transaction History